1) 井上博, 他 : 循環器病の診断と治療に関するガイドライン (2012年度合同研究班報告) : 心房細動治療 (薬物) ガイドライン (2013年改訂版). www.j-circ.or.jp/
2) 庭野慎一 : 心房細動の病型分類 : 発作性から持続性, 永続性へもう迷わない心房細動マネージメント (奥村謙編). p24-32. MEDICAL VIEW, 東京, 2012.
3) Wyse D G, et al : Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrialfibrillation. N Engl J Med 347 : 1825-1833, 2002.
5) Camm A J, et al : Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31 : 2369-2429, 2010.
8) Fuster V, et al : ACC/AHA/ESC2006 Guidelines for the Management of Patients with Atrial Fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Pracdce Guidelines and the European Society of Cardiology Committee for Practice GUidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) : developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 : e257-354, 2006.
10) Kato T, et al : Progressive nature of paroxysmai atrial fibrillation. Observations from a 14-year follow-up study. Circ J 68 : 568-572, 2004.